| MITBX | VSMPX | MITBX / VSMPX | |
| Total Expense Ratio | 1.44 | 0.02 | 7,200% |
| Annual Report Gross Expense Ratio | 1.44 | 0.02 | 7,200% |
| Fund Existence | 33 years | 11 years | - |
| Gain YTD | 9.044 | 12.876 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.97B | 2.29T | 0% |
| Annual Yield % from dividends | 0.00 | 1.07 | - |
| Returns for 1 year | 1.53 | 21.03 | 7% |
| Returns for 3 years | 8.64 | 74.33 | 12% |
| Returns for 5 years | -12.79 | 66.62 | -19% |
| Returns for 10 years | 28.18 | 238.83 | 12% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYCEX | 105.50 | 1.05 | +1.01% |
| Rydex Europe 1.25x Strategy C | |||
| LVAVX | 17.34 | 0.12 | +0.70% |
| LSV Conservative Value Equity Investor | |||
| NWAEX | 20.36 | 0.08 | +0.39% |
| Nationwide BNY Mellon Dyn US Core Eagle | |||
| WWIAX | 13.51 | 0.03 | +0.22% |
| Westwood Income Opportunity A | |||
| JFNSX | 87.14 | N/A | N/A |
| Janus Henderson Global Life Sciences S | |||